openPR Logo
Press release

Biopharma PEG Launches New Monodispersed PEGs for Better Drug Delivery

07-23-2024 12:41 PM CET | Chemicals & Materials

Press release from: Biopharma PEG Scientific Inc

Watertown, MA, July 22, 2024 - Biopharma PEG, a top supplier of PEG derivatives, is excited to introduce its new line of monodispersed PEGs. These specially sized polymers are designed to improve the stability and delivery of proteins and peptides in drugs. They are essential for Antibody-Drug Conjugate (ADC) linkers, Proteolysis Targeting Chimeras (PROTAC) linkers, and PEGylated proteins and peptides.
PEGs as ADC Linkers
PEGs act as a shield around the ADC payload, enhancing solubility and stability. This results in reduced aggregation, lower immunogenicity, better pharmacokinetics, longer circulation time, and less toxicity.
Products include:
 mPEG36-NH2 (CAS NO.: 32130-27-1)
 OH-PEG6-COOH (CAS NO.: 1347750-85-9)
 CBZ-NH-PEG3-COOH (CAS NO.: 1310327-18-4)
 OH-PEG9-OH (CAS NO.: 3386-18-3)
PEGs as PROTAC Linkers
PEG linkers are the most common in PROTAC molecules. They increase water solubility and affect cell permeability, improving oral absorption and degradation efficiency. PEG linkers also make it easy to adjust linker length and quickly assemble different molecules.
Products include:
 Fmoc-NH-PEG12-COOH (CAS NO.: 756526-01-9)
 NH2-PEG4-OH (CAS NO.: 86770-74-3)
 N3-PEG3-SPA (CAS NO.: 1245718-89-1)
 N3-PEG6-OH (CAS NO.: 86770-69-6)
PEGylated Protein & Peptide
PEGylation improves drug pharmacokinetics by reducing clearance and increasing half-life. It also reduces immunogenicity, antigenicity, toxicity, and renal clearance while maintaining drug effectiveness.
Products include:
 N3-PEG11-NH2 (CAS NO.: 1800414-71-4)
 NH2-PEG24-COOH (CAS NO.: 196936-04-6)
 mPEG11-COOH (CAS NO.: 2135793-73-4)
 mPEG6-OH (CAS NO.: 23601-40-3)
"We can provide lab to commercial scale monodispersed PEG linkers in both GMP and non-GMP grades," said Sonia Lee, [Title], Biopharma PEG. "Our monodispersed PEGs are designed to meet high standards, supporting the development of advanced pharmaceuticals."
For more information about Biopharma PEG and their monodispersed PEG products, please visit www.biochempeg.com or contact us at sales@biochempeg.com.

Biopharma PEG
108 Water Street, Suite 4D, Watertown, MA 02472, USA
TEL: 1-857-928-2050 / 1-857-366-6766
sales@biochempeg.com

Biopharma PEG is a leading supplier of PEG derivatives, dedicated to supporting the pharmaceutical, biotechnology, and medical device industries with high-quality products that enhance the performance and delivery of therapeutic agents. For more information, visit www.biochempeg.com.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biopharma PEG Launches New Monodispersed PEGs for Better Drug Delivery here

News-ID: 3593519 • Views:

More Releases from Biopharma PEG Scientific Inc

BIOPHARMA PEG Receives FDA DMF Listings for Two Key PEG Derivatives
BIOPHARMA PEG, a leading developer and supplier of high-purity polyethylene glycol (PEG) derivatives, today announced that two of its proprietary products-mPEG-pALD 20K and HZ-PEG-HZ (1K)-have successfully passed FDA review and are now listed in the U.S. Drug Master File (DMF) database. mPEG-pALD (20K) - DMF No. 040600 HZ-PEG-HZ (1K) - DMF No. 041864 These new listings mark a significant step in BIOPHARMA PEG's ongoing efforts to provide regulatory-ready, high-quality PEG solutions to the
Monodispersed PEG Linkers Enhance Antibody-Drug Conjugates (ADCs)
Antibody-drug conjugates (ADCs) combine potent small-molecule drugs with monoclonal antibodies for targeted cancer therapy. A major challenge is loading enough drug onto each antibody without compromising solubility or circulation time. Introducing polyethylene glycol (PEG) linkers between the antibody and drug payload can address this. PEG is hydrophilic, biologically inert, and FDA‐recognized as safe. As a flexible spacer, PEG "shields" the hydrophobic drug, greatly improving ADC solubility and stability. In fact,
Biopharma PEG Scientific Inc. to Showcase Comprehensive PEG Derivative Portfolio at TIDES USA 2025
Biopharma PEG Scientific Inc. to Showcase Comprehensive PEG Derivative Portfolio …
Biopharma PEG Scientific Inc., a leading provider of high-quality polyethylene glycol (PEG) derivatives, today announced its participation in TIDES USA 2025, taking place from May 19 - 22, 2025, at the Manchester Grand Hyatt San Diego. Attendees are invited to visit Biopharma PEG at Booth #913 to explore their extensive range of GMP-grade PEG products and discuss how these solutions can advance their research and development efforts. Biopharma PEG offers a
BIOPHARMA PEG Showcases DSPE-PEG-Mannose: A Cutting-Edge Polymer for Drug Delive …
Watertown, MA - March 24, 2025 - Biopharma PEG, a leading supplier of high-quality polyethylene glycol (PEG) derivatives, highlights its innovative product DSPE-PEG-Mannose, an advanced biomedical polymer with significant potential in drug delivery, tumor-targeted therapy, tissue recognition, and adhesion. Structural Advantages of DSPE-PEG-Mannose DSPE-PEG-Mannose is composed of three key components that enable its diverse applications: DSPE (1,2-Distearoyl-sn-glycero-3-phosphoethanolamine): A phospholipid with amphiphilic properties, forming stable micelles in aqueous solutions. PEG (Polyethylene Glycol): A biocompatible polymer

All 5 Releases


More Releases for CAS

Top Factor Driving Cas Nuclease Market Growth in 2025: Increasing Biotech Invest …
How Big Is the Cas Nuclease Market Expected to Be, and What Will Its Growth Rate Be? In recent times, there has been a quick escalation in the size of the cas nuclease market. The market valuation is projected to increase from $3.27 billion in 2024 to $3.89 billion in 2025, while maintaining a compound annual growth rate (CAGR) of 19.2%. This significant growth during the historical period can be traced
Altimedia Achieves Widevine CAS 3PL Partnership
Image: https://www.abnewswire.com/uploads/1671b7044637885642f07dbf55abb228.jpg Global digital media total solutions company Altimedia named a certified 3PL (Third Party Lab) partner for its Widevine CAS solution, AltiProtect-WCAS. This partnership underscores Altimedia's reliability and technical expertise in the global digital content protection solutions market. AltiProtect-WCAS, originated from the source technology of Widevine, is a conditional access solution that helps PayTV service providers prevent illegal copying and unauthorized access. With this new 3PL partnership, it's verified Altimedia offers
Visit CAS DataLoggers at WEFTEC 2022
Ernest N. Morial Convention Center, October 8 - 12, New Orleans, LA CAS DataLoggers is proud to announce that we will be exhibiting at the WEFTEC 2022 Conference! Hosted at the Morial Convention Center in New Orleans, LA on October 8-12, WEFTEC 2022 will bring together water professionals from around the world in person and virtually! This year, CAS DataLoggers President Peter Martin is attending along with CAS DataLoggers Engineering Manager
Visit CAS DataLoggers at Pittcon 2020
The World's Largest Lab Expo, March 3rd-5th in Chicago CAS DataLoggers is proud to announce that we will be exhibiting along with TandD US, LLC at Pittcon 2020! Pittcon is the world's leading annual conference and exposition on laboratory science. Hosted in Chicago, IL at McCormick Place on March 3rd-5th, Pittcon 2020 will draw a large crowd of attendees from industry, academia, and government from over 90 countries! This year, CAS
Visit CAS DataLoggers at AHR 2020
The World’s Largest HVAC event is about to get underway—the annual AHR 2020 Expo is returning to Orlando, FL on Feb 3-5th. CAS DataLoggers Sales Mgr. Peter Martin is proud to attend along with Japan’s #1 datalogger manufacturer—T&D! Come visit us at Booth #7490 to see our cutting-edge HVAC solutions for performance validation, energy audits, and more! With prices starting at just $109, T&D products give businesses and organizations an affordable
CRISPR & CRISPR-associated (Cas) Genes Market to 2027 - Global Analysis and Fore …
CRISPR and CRISPR-Associated (Cas) Genes is a genome editing tool that enables the researchers to make changes in the DNA. CRISPR-Cas9 stands for clustered regularly interspaced short palindromic repeats and CRISPR-associated protein 9. In recent years the CRISPR and CRISPR-Associated (Cas) Genes has gained lot of popularity as it offers it is cheaper, faster, accurate, and more efficient genome editing methods. The CRISPR and CRISPR-associated (Cas) Genes market is anticipated to